Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Daptomycin vs. Vancomycin in MRSA cSSSI
NCT01419184Phase 4Completed
- Sponsor
- Merck & Co.
- Start
- Sep 2011
- Primary completion
- Sep 2012
- Modality
- Cyclic Peptides, Antimicrobial Peptides, Small Molecules
- Countries
- 2
01
Overview
A Phase 4 trial of daptomycin in Skin and Skin Structure Infection (SSSI), sponsored by Merck & Co.. Started Sep 2011; status: completed.
02
Drugs
daptomycin
03
Conditions
Skin and Skin Structure Infection (SSSI)
Beyond the preview
Go deeper on NCT01419184.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01419184.